2025 Articles List

Volume 7 Issue 4

A Major Turn in U.S. Drug Laws: Cannabis Rescheduling,
Its Path Forward, Congressional Role,
and What It Means for Psychedelics

Tyler Kjorvestad, MD

Re-Parenting the Inner Adolescents with Acceptance
and Commitment Therapy (ACT): The
DNA-V/IFS Model for Psychedelic Assisted Psychotherapy

Alex Tsarev, PhD

Psychedelic Rejuvenation Hypothesis A Framework for Cellular and Psychological Restoration

Tony Montgomery, PhD

IV Ketamine-Assisted Psychotherapy for PTSD and OCD: A Case Study

Arya Tsay-Jones, MS, LPC-A Katie Coon, BSN, RN, Will Ratliff, RN, LP

Psilocybin Therapy—A Breakthrough Alternative to SSRIs for Depression

Tyler Kjorvestad, MD

Psilocybin-Assisted Therapy for Obsessive-Compulsive Disorder: A Review

Christian Barrett, M.D. and Tyler Kjorvestad, M.D.

Sirolimus Augmentation of Esketamine Treatment in Treatment-Resistant Depression: A Pilot Evaluation

Michael Kielmanowicz, M.D., William Webb, M.D., Ph.D., Tyler Kjorvestad M.D.

Case Study: Integrating Ketamine-Assisted Therapy (KAP)
with EMDR for Intractable Depression and Trauma

Alissa Hirshfeld, MA, LMFT

On the Spiritualized. Aesthetic in Psychedelic Clinical settings

William Winter, Ph.D.

“Keep Your Wits About You” – Purposed Language
and Terminology in Hallucinogenic Research
and Therapy

Abigail Wagle, B.S. M2